Health Technology Assessment Unit, Clinical Research Center, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Public Health, Faculty of Medicine, Health Technology Assessment Unit, Clinical Research Center, School of Medicine, Pontificia Universidad Católica de Chile, Pontificia Universidad Católica de Chile, Diagonal Paraguay, 362, Santiago, Chile.
BMC Palliat Care. 2023 Jan 12;22(1):5. doi: 10.1186/s12904-022-01122-z.
Access to palliative care is an emerging global public health challenge. In Chile, a palliative care law was recently enacted to extend palliative care coverage to the non-oncologic population. Thus, a reliable and legitimate estimate of the demand for palliative care is needed for proper health policy planning.
To estimate the demand for Palliative Care in Chile.
Diseases likely to require palliative care were identified according to literature and expert judgement. Annual deaths of diseases identified were estimated for the periods 2018-2020. Demand estimation corresponds to the identification of the proportion of deceased patients requiring palliative care based on the burden of severe health-related suffering. Finally, patient-years were estimated based on the expected survival adjustment.
The estimated demand for palliative care varies between 25,650 and 21,679 patients depending on the approximation used. In terms of annual demand, this varies between 1,442 and 10,964 patient-years. The estimated need has a minor variation between 2018 and 2019 of 0.85% on average, while 2020 shows a slightly higher decrease (7.26%).
This is a replicable method for estimating the demand of palliative care in other jurisdictions. Future studies could approach the demand based on the decedent population and living one for a more precise estimation and better-informed health planning. It is hoped that our methodological approach will serve as an input for implementing the palliative care law in Chile, and as an example of estimating the demand for palliative care in other jurisdictions.
获得姑息治疗是全球公共卫生面临的一个新兴挑战。智利最近颁布了姑息治疗法，将姑息治疗覆盖范围扩大到非肿瘤人群。因此，需要对姑息治疗的需求进行可靠和合法的估计，以进行适当的卫生政策规划。
估计智利姑息治疗的需求。
根据文献和专家判断确定可能需要姑息治疗的疾病。估计了 2018-2020 年期间确定疾病的年死亡人数。需求估计对应于根据严重与健康相关的痛苦负担确定需要姑息治疗的死亡患者的比例。最后，根据预期生存调整估计了患者年数。
姑息治疗的估计需求在 25650 至 21679 名患者之间变化，具体取决于使用的近似值。就年度需求而言，这在 1442 至 10964 名患者年之间变化。估计的需求在 2018 年和 2019 年之间平均变化 0.85%，而 2020 年略有下降（7.26%）。
这是一种在其他司法管辖区估计姑息治疗需求的可复制方法。未来的研究可以根据死亡人口和在世人口来研究需求，以进行更准确的估计和更明智的卫生规划。我们希望我们的方法能够为智利姑息治疗法的实施提供投入，并为其他司法管辖区姑息治疗需求的估计提供范例。
